- Report
- September 2025
- 150 Pages
United States
From €5332EUR$5,950USD£4,575GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5332EUR$5,950USD£4,575GBP
- Report
- September 2025
- 85 Pages
United States
From €3137EUR$3,500USD£2,691GBP
- Report
- June 2026
- 110 Pages
United States
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2026
- 120 Pages
United States
From €4257EUR$4,750USD£3,652GBP
- Report
- November 2025
- 92 Pages
Europe
From €3540EUR$3,950USD£3,037GBP
- Report
- October 2025
- 84 Pages
United States
From €4033EUR$4,500USD£3,460GBP
- Report
- October 2025
- 93 Pages
Middle East, Oman
From €4033EUR$4,500USD£3,460GBP
- Report
- October 2025
- 90 Pages
Asia Pacific
From €4033EUR$4,500USD£3,460GBP
From €4033EUR$4,500USD£3,460GBP
From €4033EUR$4,500USD£3,460GBP
- Report
- October 2025
- 88 Pages
Middle East
From €4033EUR$4,500USD£3,460GBP
- Report
- October 2025
- 100 Pages
Asia Pacific
From €4033EUR$4,500USD£3,460GBP
- Report
- September 2025
- 99 Pages
United States
From €4033EUR$4,500USD£3,460GBP
- Report
- July 2025
- 236 Pages
Global
From €5248EUR$6,061USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5248EUR$6,061USD£4,350GBP
- Report
- August 2023
- 334 Pages
Global
From €4765EUR$5,503USD£3,950GBP
- Report
- January 2021
- 184 Pages
Global
From €4391EUR$4,899USD£3,767GBP
- Report
- March 2020
- 210 Pages
China
From €4391EUR$4,899USD£3,767GBP
- Report
- January 2020
- 473 Pages
Global
From €4391EUR$4,899USD£3,767GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more